Shares of biotechnology companyAltimmune (ALT) are up 28 percent over the past year, but are also up nearly four-fold from their 52-week lows. One trader sees shares giving back some of their recent gains. That’s based on the October $13 put. With 42 days until expiration, 6,077 contracts traded compared to a prior open interest of 104, for a 58-fold surge in volume. The buyer of the puts paid $1.70 to get into the trade. The stock recently traded around $20, so it would need to lose $7, or about 35 percent, for the option to move in-the-money. The company is an early-stage player...
More








